Menu

Blog

Page 7373

Jul 15, 2020

Episode 1: Driving The Telescope (Hubble – Eye in the Sky miniseries)

Posted by in category: space

The first episode of “Hubble – Eye in the Sky” is here! 🎥

Have you ever wondered how a telescope in space is operated from down on Earth? Welcome to the Hubble control center. Find out how extraordinarily detailed observations are made with an orbiting space telescope, and get a look at Hubble’s on-the-ground replica that engineers and scientists use down here to fix problems up there.

For more on this video series, visit https://go.nasa.gov/3eveFO1.

Jul 15, 2020

Details on SpaceX Starlink beta emerge along with photos of user terminals

Posted by in category: internet

Starlink beta trials will start in Northern US and parts of Canada, new FAQ says.

Jul 15, 2020

Scientists find new link between delirium and brain energy disruption

Posted by in categories: biotech/medical, neuroscience

Scientists from Trinity College Dublin have discovered a new link between impaired brain energy metabolism and delirium—a disorienting and distressing disorder particularly common in the elderly and one that is currently occurring in a large proportion of patients hospitalized with COVID-19 [15th of July 2020].

While much of the research was conducted in mice, additional work suggests overlapping mechanisms are at play in humans because cerebrospinal fluid (CSF) collected from patients suffering from delirium also contained tell-tale markers of altered brain glucose .

Collectively, the research, which has just been published in the Journal of Neuroscience, suggests that therapies focusing on brain energy metabolism may offer new routes to mitigating delirium.

Jul 15, 2020

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

Posted by in categories: biotech/medical, business, chemistry, health, information science, robotics/AI

No industry will be spared.


The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and there is about 90% chance of failure. It is very different from the IT business, where only the paranoid survive but a business where executives need to plan decades ahead and execute. So when the revolution in artificial intelligence fueled by credible advances in deep learning hit in 2013–2014, the pharmaceutical industry executives got interested but did not immediately jump on the bandwagon. Many pharmaceutical companies started investing heavily in internal data science R&D but without a coordinated strategy it looked more like re-branding exercise with the many heads of data science, digital, and AI in one organization and often in one department. And while some of the pharmaceutical companies invested in AI startups no sizable acquisitions were made to date. Most discussions with AI startups started with “show me a clinical asset in Phase III where you identified a target and generated a molecule using AI?” or “how are you different from a myriad of other AI startups?” often coming from the newly-minted heads of data science strategy who, in theory, need to know the market.

However, some of the pharmaceutical companies managed to demonstrate very impressive results in the individual segments of drug discovery and development. For example, around 2018 AstraZeneca started publishing in generative chemistry and by 2019 published several impressive papers that were noticed by the community. Several other pharmaceutical companies demonstrated impressive internal modules and Eli Lilly built an impressive AI-powered robotics lab in cooperation with a startup.

Continue reading “Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry” »

Jul 15, 2020

Chainalysis Says Bitcoin Scammed From Twitter Users Is ‘On the Move’

Posted by in categories: bitcoin, cryptocurrencies, cybercrime/malcode

Scammers are everywhere now.


The defrauded bitcoin amassed during Wednesday’s monumental Twitter hack is already “on the move,” according to cryptocurrency tracing firm Chainalysis.

Jul 15, 2020

Nuclear blast sends star hurtling across galaxy

Posted by in category: cosmology

A star has been sent hurtling across the galaxy after undergoing a partial supernova, astronomers say.

A supernova is a powerful explosion that occurs when some stars reach the ends of their lives; in this case, the blast was not sufficient to destroy it.

Instead, it sent the star hurtling through space at 900,000 km/hr.

Jul 15, 2020

Geneticists sequence the complete human X chromosome for the first time

Posted by in categories: biotech/medical, genetics, life extension

For the first time, scientists have determined the complete sequence of a human chromosome, namely the X chromosome, from ‘telomere to telomere’. This is truly a complete sequencing of a human chromosome, with no gaps in the base pair read and at an unprecedented level of accuracy.

A step closer towards the complete blueprint of a human being

The Human Genome Project was a 13-year-long, publicly funded project initiated in 1990 with the objective of determining the DNA sequence of the entire human genome.

Jul 15, 2020

World population expected to peak by 2064

Posted by in category: economics

A new study, published this week in The Lancet, concludes that the global population is likely to peak in 2064 at 9.7 billion and fall to 8.8 billion by century’s end. The report foresees major shifts in geopolitical power – producing a more multi-polar world – with 23 countries seeing their populations shrink by more than half as a result of declining fertility rates. Liberal immigration policies could help to maintain population sizes and economic growth, the authors suggest.

Jul 15, 2020

The Air Force Is Moving From Smart Bombs to Thinking Bombs

Posted by in category: futurism

Golden Horde introduces swarm tactics to guided munitions—but it also lets the weapons make real decisions.

Jul 15, 2020

Juvenescence moves IPO to second half of 2020

Posted by in category: biotech/medical

UK biotech valued at $500m will use public offering to move 5 life-extension technologies into phase 2 trials.